Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 7/20 | 0.71 |
| ▸ | CTSS | P25774 | 3/20 | 0.57 |
| ▸ | CTSK | P43235 | 3/20 | 0.57 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.55 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.55 |
| ▸ | TACR1 | P25103 | 1/20 | 0.52 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aurantiamide Acetate SCHEMBL30004267 | 1.00 | CTSL (0.71) | CTSLCTSSCTSKPIN1PSMB5 | |
| Aurantiamide Acetate SCHEMBL31084254 | 1.00 | CTSL (0.71) | CTSLCTSSCTSKPIN1PSMB5 | |
| Aurantiamide Acetate SCHEMBL30532189 | 1.00 | CTSL (0.71) | CTSLCTSSCTSKPIN1PSMB5 | |
| Aurantiamide Acetate SCHEMBL27679112 | 1.00 | CTSL (0.71) | CTSLCTSSCTSKPIN1PSMB5 | |
| SCHEMBL24368215 | 0.93 | CTSL (0.63) | CTSLCTSSCTSKPIN1PSMB5 | |
| SCHEMBL24368216 | 0.93 | CTSL (0.63) | CTSLCTSSCTSKPIN1PSMB5 | |
| SCHEMBL24368196 | 0.92 | CTSL (0.61) | CTSLCTSSCTSKPIN1PSMB5 | |
| SCHEMBL24368183 | 0.92 | CTSL (0.61) | CTSLCTSSCTSKPIN1PSMB5 | |
| SCHEMBL28530796 | 0.92 | CTSL (0.61) | CTSLCTSSCTSKPIN1PSMB5 | |
| SCHEMBL4366379 | 0.92 | CTSL (0.60) | CTSLCTSSCTSKPIN1PSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) | 2009-10-01 | — | — | US | claimed |
| CN-118453623-A | Application of alisol B in preventing and treating central precocity | 俞建 | 2024-08-09 | — | — | CN | disclosed |
| CN-115650875-B | Zantedeschia aethiopica derivative and preparation method and application thereof | 贵州省天然产物研究中心 | 2024-05-14 | — | — | CN | disclosed |
| CN-112500308-B | Golden amide alcohol ester and fluorinated derivative thereof, and preparation method and application thereof | 澳门科技大学 | 2023-10-03 | — | — | CN | disclosed |
| CN-111909051-B | N- [ 4-phenyl-3- (benzoylamino) -1, 1-trifluoro-butyl-2-yl ] -phenylalaninol derivative and preparation method and application thereof | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2022-12-27 | — | — | CN | disclosed |
| US-11377418-B2 | Compounds and methods for treating influenza | MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (MO) | 2022-07-05 | — | — | US | disclosed |
| US-20220127220-A1 | COMPOUNDS AND METHODS FOR TREATING INFLUENZA | MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (MO) | 2022-04-28 | — | — | US | disclosed |
| CN-111909051-A | N- [ 4-phenyl-3- (benzoylamino) -1,1, 1-trifluoro-butyl-2-yl ] -phenylalaninol derivative and preparation method and application thereof | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2020-11-10 | — | — | CN | disclosed |
| US-9023809-B2 | Phenylalanine dipeptide derivatives, compositions and use thereof | THE KEY LABORATORY OF CHEMISTRY FOR NATURAL PRODUCTS OF GUIZHOU PROVINCE AND CHINESE ACADEMY OF SCIENCES (CN) | 2015-05-05 | — | — | US | disclosed |
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | DNPEP, PEPD, VIP | CTSL 591/4885CTSS 3153/4885CTSK 2637/4885 |
| US-20220127220-A1 | COMPOUNDS AND METHODS FOR TREATING INFLUENZA | H1-3, HRH3, H1-4 | CTSL 1708/4885CTSS 1088/4885CTSK 1076/4885 |
| US-11377418-B2 | Compounds and methods for treating influenza | H1-3, HRH3, H1-4 | CTSL 1708/4885CTSS 1088/4885CTSK 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.